Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

160.26 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >
The 5 Best Healthcare Stocks to Buy Now: September 2023
Unearth the best healthcare stocks offering attractive entry points and opportunities for significant returns. Start investing today! 
Via InvestorPlace
Analyst Ratings for Johnson & Johnson
Via Benzinga
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
3 Shaky Stocks to Sell in September Before It’s Too Late
Here's a list of stocks to sell that can put your portfolio at potential risk of losses due to legal exposure or poor performance. 
Via InvestorPlace
The 7 Best Dow Stocks to Buy Now: September 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Is J&J a Buy After the Kenvue Separation?
J&J shares have been on the decline. 
Via The Motley Fool
Check Out What Whales Are Doing With JNJ
Via Benzinga
This Is What Whales Are Betting On Johnson & Johnson
Via Benzinga
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
The recently spun-off Kenvue looks to be a high-quality dividend stock. 
Via The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
Via InvestorPlace
The 25 Best Stocks By Shareholder Wealth Creation (1926-2022)
Via Talk Markets
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population
Janssen, a unit of Johnson & Johnson (NYSE: JNJ),  
Via Benzinga
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?
Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
7 Retirement Stocks That Every Long-Term Investor Should Own Now
Boost your investment portfolio with these seven top long-term retirement stocks to buy and hold for this decade. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? 
Via Benzinga
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation
Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth in  
Via Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
On Friday, Judge Thomas Rose, serving in the U.S. 
Via Benzinga
3 Dow Stocks to Sell in September Before They Crash and Burn
Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032
These companies all offer goods or services most of us use regularly. 
Via The Motley Fool
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
Johnson & Johnson has completed its separation of Kenvue. 
Via The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs? 
Via The Motley Fool
Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
News of psychedelics and who is using them keeps making headlines. 
Via Benzinga
7 Cash Cow Stocks for Recession-Resilient Dividends
These cash cow stocks are must buys for those looking to craft a recession-resistant portfolio amidst choppy market action. 
Via InvestorPlace
3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth
These restaurant and beverage companies are dependable enough to deliver stable earnings and share price gains for many years ahead. 
Via InvestorPlace
When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong
Generative AI has plenty of potential and utility, but that does not mean they get everything right. Here are three ChatGPT stock mistakes. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?
The change won't have much of an immediate impact for investors either way. 
Via The Motley Fool
2 Dividend Kings That Face Massive Legal Risks
Are the payouts for these two dividend stocks still safe? 
Via The Motley Fool
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
The healthcare giant's immunology drug Stelara brought in more than $9 billion in revenue last year. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
73 74 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.